Skip to main content

Advertisement

SpringerLink
Log in

Osteogenic progenitors in bone marrow aspirates have clinical potential for tibial non-unions healing in diabetic patients

  • Original Paper
  • Published:
International Orthopaedics Aims and scope Submit manuscript

Abstract

Purpose

There is a significantly higher incidence of delayed unions, non-unions, and increased healing time in diabetic patients compared with non-diabetic patients. Studies suggest that diabetics suffer from deficiencies of pancreatic stem/progenitor cells, and a clinically relevant question arises concerning the availability and functionality of progenitor cells obtained from bone marrow of diabetics for applications in bone repair.

Methods

We have evaluated the cellularity and frequency of osteogenic mesenchymal stem cells (MSCs) in bone marrow from 54 diabetic patients (12 with type 1 and 42 with type 2) with tibial non-unions. These patients were treated with bone marrow MSCs (BM-MSCs) delivered in an autologous bone marrow concentrate (BMC). Clinical outcomes and marrow cellularity were compared to 54 non-diabetic, matched patients with tibial non-unions also treated with BMC.

Results

After adjusting for age and sex, no differences were identified with respect to bone marrow cellularity and MSC number among the diabetic and non-diabetic groups and both groups received approximately the same number of MSCs on average. BMC treatment promoted non-union healing in 41 diabetic patients (76 %) and 49 non-diabetic patients (91 %), but the non-diabetic patients healed more quickly and produced a larger volume of callus.

Conclusion

We recommend that diabetic patients be treated with an increased number of progenitor cells by increasing the bone marrow aspiration volume. We also anticipate a need to extend the time of casting and non-weight bearing for diabetic patients as compared with non-diabetic patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bhansali A, Upreti V, Khandelwal N et al (2009) Efficacy of autologous bone marrow-derived stem cell transplantation in patients with type 2 diabetes mellitus. Stem Cells Dev 18:1407–1415

    Article  CAS  PubMed  Google Scholar 

  2. Dumic-Cule I, Pecina M, Jelic M, Jankolija M, Popek I, Grgurevic L, Vukicevic S (2015) Biological aspect of segmental bone defects. Int Orthop 39:1005–1011

    Article  PubMed  Google Scholar 

  3. Follak N, Kl¨oting L, Wolf E, Merk H (2004) Delayed remodeling in the early period of fracture healing in spontaneously diabetic BB/OK rats depending on the diabetic metabolic state. Histol Histopathol 19:473–486

    CAS  PubMed  Google Scholar 

  4. Gandhi A, Beam HA, O’Connor JP, Parsons JR, Lin SS (2005) The effects of local insulin delivery on diabetic fracture healing. Bone 37:482–490

    Article  CAS  PubMed  Google Scholar 

  5. Ganesh SP, Pietrobon R, Cecilio WA, Pan D, Lightdale N, Nunley JA (2005) The impact of diabetes on patient outcomes after ankle fracture. J Bone Joint Surg Am 87:1712–1718

    Article  PubMed  Google Scholar 

  6. Hernigou P, Poignard A, Beaujean F, Rouard H (2005) Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. J Bone Joint Surg Am 87:1430–1437

    Article  PubMed  Google Scholar 

  7. Hernigou P, Guissou I, Homma Y, Poignard A, Chevallier N, Rouard H, Flouzat Lachaniette CH (2015) Percutaneous injection of bone marrow mesenchymal stem cells for ankle non-unions decreases complications in patients with diabetes. Int Orthop 39:1639–1643

    Article  PubMed  Google Scholar 

  8. Kayal RA, Tsatsas D, Bauer MA, Allen B, Al-Sebaei MO, Kakar S, Leone CW, Morgan EF, Gerstenfeld LC, Einhorn TA, Graves DT (2007) Diminished bone formation during diabetic fracture healing is related to the premature resorption of cartilage associated with increased osteoclast activity. J Bone Miner Res 22:560–568

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Le Nail LR, Stanovici J, Fournier J, Splingard M, Domenech J, Rosset P (2014) Percutaneous grafting with bone marrow autologous concentrate for open tibia fractures: analysis of forty three cases and literature review. Int Orthop 38:1845–1853

    Article  PubMed  Google Scholar 

  10. Loder RT (1988) The influence of diabetes mellitus on the healing of closed fractures. Clin Orthop Relat Res 232:210–216

    PubMed  Google Scholar 

  11. Loomans CJ, de Koning EJ, Staal FJ, Rookmaaker MB, Verseyden C, de Boer HC, Verhaar MC, Braam B, Rabelink TJ, van Zonneveld AJ (2004) Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 53:195–199

    Article  CAS  PubMed  Google Scholar 

  12. Lu H, Kraut D, Gerstenfeld LC, Graves DT (2003) Diabetes interferes with the bone formation by affecting the expression of transcription factors that regulate osteoblast differentiation. Endocrinology 144:346–352

    Article  CAS  PubMed  Google Scholar 

  13. Tölli H, Kujala S, Jämsä T, Reindeer JP (2011) bone extract can heal the critical-size rat femur defect. Int Orthop 35:615–622

    Article  PubMed  Google Scholar 

  14. Wang X, Wang Y, Gou W, Lu Q, Peng J, Lu S (2013) Role of mesenchymal stem cells in bone regeneration and fracture repair: a review. Int Orthop 37:2491–2498

    Article  PubMed  PubMed Central  Google Scholar 

  15. Zhou B, Bi YY, Han ZB, Ren H, Fang ZH, Yu XF, Poon MC, Han ZC (2006) G-CSF-mobilized peripheral blood mononuclear cells from diabetic patients augment neovascularization in ischemic limbs but with impaired capability. J Thromb Haemost 4:993–1002

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Ted Sand and Richard Suzuki and the other members of Celling Biosciences for the review of the final manuscript, and their help in translation.

Author information

Authors and Affiliations

  1. Orthopaedic Surgery, Hôpital Henri Mondor, University Paris East (UPEC), 94010, Creteil, France

    Charles Henri Flouzat-Lachaniette, Clemence Heyberger, Charlie Bouthors, François Roubineau & Philippe Hernigou

  2. EFS Cell Therapy Facility, Hôpital Henri Mondor, University Paris East (UPEC), 94010, Creteil, France

    Nathalie Chevallier & Helene Rouard

Authors
  1. Charles Henri Flouzat-Lachaniette
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Clemence Heyberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Charlie Bouthors
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. François Roubineau
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nathalie Chevallier
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Helene Rouard
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Philippe Hernigou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Philippe Hernigou.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Flouzat-Lachaniette, C.H., Heyberger, C., Bouthors, C. et al. Osteogenic progenitors in bone marrow aspirates have clinical potential for tibial non-unions healing in diabetic patients. International Orthopaedics (SICOT) 40, 1375–1379 (2016). https://doi.org/10.1007/s00264-015-3046-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00264-015-3046-6

Keywords

Search

Navigation